A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone

Duman S., Kuru D., Gumussoy M., KİREMİTCİ S., GÖKCAN H., Ulas B., ...More

EUROPEAN RADIOLOGY, vol.34, no.6, pp.3882-3888, 2024 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 34 Issue: 6
  • Publication Date: 2024
  • Doi Number: 10.1007/s00330-023-10441-5
  • Journal Name: EUROPEAN RADIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.3882-3888
  • Keywords: Magnetic resonance elastography, Metabolic dysfunction-associated steatohepatitis, Metabolic dysfunction-associated steatotic liver disease, Non-invasive, Nonalcoholic fatty liver disease
  • Ankara University Affiliated: Yes

Abstract

Objectives The aims of the present study were to investigate a combination of magnetic resonance elastography (MRE) and vibration-controlled transient elastography (VCTE) or MRE and fibrosis score 4 (FIB-4) in the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Methods Between November 5, 2021, and March 4, 2022, a total of 119 consecutive patients with MASLD were included. Liver stiffness was measured using liver biopsy, MRE, VCTE, and FIB-4. Data were collected from outpatient visit charts. Significant fibrosis was defined as >= stage 2 fibrosis.Results All 119 MASLD patients were Caucasian, and their median age was 55 years. MRE, VCTE, and FIB-4 demonstrated significant accuracy in the detection of significant fibrosis with an area under the ROC curve (AUC) of 0.848 +/- 0.036 (p < 0.001), 0.632 +/- 0.052 (p = 0.012), and 0.664 +/- 0.051 (p = 0.001), respectively. However, the diagnostic performance of MRE was superior compared to that of VCTE (AUC difference: 0.216 +/- 0.053, p < 0.001) and FIB-4 (AUC difference: 0.184 +/- 0.058, p = 0.001). With logistic regression analysis, it was determined that when compared to MRE alone, a combination of MRE and TE (p = 0.880) or MRE and FIB-4 (p = 0.455) were not superior for detecting significant fibrosis.Conclusions MRE alone is an accurate and non-invasive method for the identification of MASLD patients with significant fibrosis.